← Open Payments lookup

ARIYA HAQ: Open Payments

NPI 1740967678 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,499 in 103 payments from 21 companies in 2025. Trend: 2023 $924 · 2024 $1,622 · 2025 $2,499

Food & beverage: $2,499
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP16$323
Regeneron Healthcare Solutions, Inc.10$315
Novartis Pharmaceuticals Corporation10$278
GlaxoSmithKline, LLC.11$229
Organon LLC8$181
ARS Pharmaceuticals Operations, Inc.7$164
Takeda Pharmaceuticals U.S.A., Inc.6$157
Genentech USA, Inc.5$142
Grifols USA, LLC4$117
BioCryst US Sales Co., LLC5$95

Products named: DUPIXENT, Xolair, TRELEGY ELLIPTA, NEFFY, FASENRA, VTAMA, Rhapsido, Gamunex-C.

Industry payments across TX — which companies pay providers there.